Magnetic resonance imaging appearance of the hands and feet in patients with early rheumatoid arthritis.

…, A Lardé, F Lapègue, E Solau-Gervais… - The Journal of …, 2003 - jrheum.org
OBJECTIVE: To describe the magnetic resonance (MRI) imaging findings of the feet in patients
with early rheumatoid arthritis (RA), and to compare MRI appearance of the feet with that …

Non–TNF-targeted biologic vs a second anti-TNF drug to treat rheumatoid arthritis in patients with insufficient response to a first anti-TNF drug: a randomized clinical …

…, C Marcelli, J Sellam, O Meyer, E Solau-Gervais… - Jama, 2016 - jamanetwork.com
Importance One-third of patients with rheumatoid arthritis show inadequate response to tumor
necrosis factor α (TNF-α) inhibitors; little guidance on choosing the next treatment exists. …

Step-down strategy of spacing TNF-blocker injections for established rheumatoid arthritis in remission: results of the multicentre non-inferiority randomised open-label …

…, P Gaudin, O Brocq, E Solau-Gervais… - Annals of the …, 2016 - ard.bmj.com
Tumour necrosis factor (TNF)-blocker tapering has been proposed for patients with rheumatoid
arthritis (RA) in remission. Objective The trial aims to compare the effect of progressive …

Maintenance of infliximab treatment in ankylosing spondylitis: results of a one‐year randomized controlled trial comparing systematic versus on‐demand treatment

…, T Pham, E SolauGervais… - Arthritis & …, 2008 - Wiley Online Library
Objective Continuous treatment with the anti–tumor necrosis factor α (anti‐TNFα) antibody
infliximab is efficacious in ankylosing spondylitis (AS), whereas treatment discontinuation …

Exposition to anti-TNF drugs during pregnancy: outcome of 15 cases and review of the literature

JM Berthelot, M De Bandt, P Goupille, E Solau-Gervais… - Joint Bone Spine, 2009 - Elsevier
OBJECTIVE: To report on the outcome of 15 cases of pregnancies in women treated with
anti-TNF drugs during conception or pregnancy METHODS: French rheumatologists …

A tool to identify recent or present rheumatoid arthritis flare from both patient and physician perspectives: the 'FLARE'instrument

…, T Pham, A Saraux, E Solau-Gervais… - Annals of the …, 2012 - ard.bmj.com
Introduction There is a lack of consensus about the definition of flare of rheumatoid arthritis (RA)
and a measurement tool. Objectives To develop a self-administered tool integrating the …

Relationship between inflammation and infliximab pharmacokinetics in rheumatoid arthritis

…, E SolauGervais… - British journal of …, 2014 - Wiley Online Library
Aims Infliximab, an anti‐tumour necrosis factor‐α monoclonal antibody, is indicated in
rheumatoid arthritis ( RA ). Our objective was to evaluate the influence of the sources of infliximab …

Anti-tumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritis

…, P Lafforgue, C Marcelli, E Solau-Gervais… - Annals of the …, 2008 - ard.bmj.com
Objective: To assess anti-tumour necrosis factor (anti-TNF) agents in patients with refractory
systemic rheumatoid vasculitis (SRV). Methods: 1200 rheumatologists and internists were …

Efficacy and safety of biologics in relapsing polychondritis: a French national multicentre study

…, A Konaté, A Mékinian, E Solau-Gervais… - Annals of the …, 2018 - ard.bmj.com
Objectives To assess the efficacy and the safety of biologics in a cohort of patients with
relapsing polychondritis (RP). Methods We conducted a French multicentre retrospective cohort …

[PDF][PDF] Subcutaneous abatacept in patients with polyarticular‐course juvenile idiopathic arthritis: results from a phase III open‐label study

…, N Rubio‐Pérez, E Solau Gervais… - Arthritis & …, 2018 - Wiley Online Library
Objective To investigate the pharmacokinetics, effectiveness, and safety of subcutaneous (
SC ) abatacept treatment over 24 months in patients with polyarticular‐course juvenile …